ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial.

Slides:

Advertisements

Similar presentations

Www. Clinical trial results.org The RAVEL Study A RAndomised (double blind) study with the Sirolimus coated BX™ VElocity balloon expandable stent (CYPHER™)

Advertisements

J. Mehilli, MD, G. Richard, F-J. Neumann, S. Massberg, K-L. Laugwitz, J. Pache, J. Hausleiter, I. Ott, M. Fusaro, T. Ibrahim, A. Schömig, A. Kastrati Deutsches.

M.Unverdorben; TCT Problem The treatment of stenoses of small coronary arteries (SVD) and of restenoses after stent deployment (ISR) still show.

Total Knee Arthroplasty with Retention of Both Cruciate Ligaments. A Nine to Eleven-Year Follow-up Study* by J.-M. CLOUTIER, P. SABOURET, and A. DEGHRAR.

Two-Year Outcomes After Everolimus- or Sirolimus- Eluting Stents in Patients With Coronary Artery Disease in the ISAR-TEST 4 Trial Robert A. Byrne, Adnan.

Rapamycin- and Paclitaxel-Eluting Stents With Identical Biodegradable Polymeric Coating and Design Trial Presented at The American College of Cardiology.

Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons Presented at The American Heart Association Scientific Session 2006 Presented by Dr.

Neointimal Modification with Scoring-Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients with Restenosis in Drug- Eluting Coronary Stents Deutsches.

Slow-rate release polymer-based paclitaxel- eluting stent compared with bare stent in patients with single complex coronary lesions TAXUS V Presented at.

Two-Year Outcomes After Everolimus- or Sirolimus- Eluting Stents in Patients With Coronary Artery Disease in the ISAR-TEST 4 Trial Robert A. Byrne, Adnan.

A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients TReated with Endothelial Progenitor Cell CapTuring Stents for De Novo.

Harmonizing Outcomes with RevascularIZatiON and Stents (HORIZONS) Trial HORIZONS Trial.

Direct Stenting is Better (Debate Session) 동아의대 김 무 현.

Prospective, Randomized Trial of Paclitaxel-Eluting Balloon versus Paclitaxel-Eluting Stent versus Balloon Angioplasty for Treatment of Coronary Restenosis.

Endeavor 4: A Randomized Comparison of a Zotarolimus- Eluting Stent and a Paclitaxel- Eluting Stent in Patients with Coronary Artery Disease Martin B.

ISAR-CABG Objective To compare the efficacy of DES with BMS in a randomized trial powered for clinical events Sample 610 patients with de novo SVG lesions.

Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Donor Pre-Treatment With Dopamine on.

Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implantation of a Drug-Eluting Stent With a Different.

University of Modena and Reggio Emilia Vascular Surgery – Director: prof. Coppi Silingardi R. Veronesi J. Gennai S.

Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Paradigm shifts in cardiovascular medicine J Am.

Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical restenosis after coronary stenting: perspectives.

Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Heparin-Bonded Covered Stents Versus Bare-Metal Stents.

Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pilot Trial of Cryoplasty or Conventional Balloon.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.

Randomized, non-inferiority trial of three limus agent- eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results:

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Randomized Trial of Paclitaxel- Versus Sirolimus-Eluting.

Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON) Trial Presented at The American College.

Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Coronary Anatomy and Stenting Technique.

From: Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions: 2-Year Follow-Up From the Zilver PTX Randomized and Single-Arm.

Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting.

Global Experience with Peripheral DCBs/Stent Studies: C.R. Bard

DCB for In-Stent Restenosis: Is It Superior to DES?

NORSTENT Trial design: Patients with obstructive coronary artery disease were randomized to a drug-eluting stent (DES) (n = 4,504) versus a bare-metal.

Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation (ISAR-TRIPLE Trial) - press conference - Katrin.

Circ Cardiovasc Interv

Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Chronic Total Coronary Occlusion With Well‐Developed Collaterals by Se Yeon Choi,

Risk Factors for Rehospitalization for Acute Coronary Syndromes and Unplanned Revascularization Following Acute Myocardial Infarction by Suzanne V. Arnold,

Circ Cardiovasc Interv

Circ Cardiovasc Interv

Circ Cardiovasc Interv

Catheter-Based Treatment of Coronary Artery Disease

AcoArt I Trial design: Patients with femoropopliteal artery disease were randomized to paclitaxel-coated balloon angioplasty (n = 100) vs. standard peripheral.

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to- treat analysis of amputation-free and overall survival in patients.

BBK II Trial design: Patients undergoing a two-stent approach for a de novo bifurcation lesion were randomized in a 1:1 fashion to either culotte stenting.

Compare-Acute Trial design: STEMI patients undergoing primary PCI were randomized to fractional flow reserve (FFR)-guided complete revascularization (n.

Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: A multicenter prospective randomized study Jean-Pierre.

FAIR Trial design: Patients with SFA in-stent restenosis (ISR) were randomized to either a paclitaxel-coated balloon (DCB) (dose 3.5 μg/mm2) or routine.

EXCITE ISR Trial design: Participants with femoropopliteal in-stent restenosis were randomized to excimer laser atherectomy + adjunctive angioplasty (n.

Journal of Indian College of Cardiology

ILLUMENATE Trial design: Patients with superficial femoral artery (SFA) and/or popliteal arterial stenoses were randomized in a 2:1 fashion to either balloon.

Correlation between maximal workload as achieved during a physical exercise test (treadmill or bicycle; horizontal axis) and left superficial femoral artery.

A randomized phase II study of Xilonix, a targeted therapy against interleukin 1α, for the prevention of superficial femoral artery restenosis after percutaneous.

Paclitaxel-coated balloon reduces target lesion revascularization compared with standard balloon angioplasty Nicholas Candy, MBBS, Eugene Ng, MBBS, Ramesh.

(p < 0.05 for paclitaxel angioplasty vs. either control)

Drug-eluting stents for in-stent restenosis

(p < for noninferiority)

Role of Stenting in Acute MI: PAMI Stent Pilot Trial

(p = for noninferiority)

SMART-STRATEGY Trial design: Patients with a bifurcation coronary lesion were randomized to a conservative strategy (n = 128) vs. an aggressive strategy.

Drug-eluting balloon angioplasty versus uncoated balloon angioplasty in patients with femoropopliteal arterial occlusive disease Hidde Jongsma, MD, Joost.

Flow diagram for exclusions of trials identified RCT indicates randomized controlled trial Hulten E, et al. Arch Intern Med 2006;166:

Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease Tzu-Ting Kuo, MD, Po-Lin Chen, MD, Chun-Yang.

Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric.

Baseline Characteristics of the Patients – Part I

Left panel: Correlation between left superficial femoral artery (SFA) transcutaneous partial oxygen pressure (PO2) index (horizontal axis) and the simultaneously.

American College of Cardiology Presented by Dr. Adnan Kastrati

Results of a randomized clinical trial of external beam radiation to prevent restenosis after superficial femoral artery stenting Eric Therasse, MD,

Angiographic image of the angioplasty-balloon-occluded left superficial femoral artery (SFA; left panel), which is partly filled with radiographic contrast.

Zoltán Ruzsa et al. JCIN 2018;11:

Presentation transcript:

ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial by Ilka Ott, Salvatore Cassese, Philipp Groha, Birgit Steppich, Felix Voll, Martin Hadamitzky, Tareq Ibrahim, Sebastian Kufner, Karl Dewitz, Theresa Wittmann, Albert Markus Kasel, Karl‐Ludwig Laugwitz, Heribert Schunkert, Adnan Kastrati, and Massimiliano Fusaro J Am Heart Assoc Volume 6(7):e006321 July 25, 2017 © 2017 Ilka Ott et al.

Flow diagram of the study. Flow diagram of the study. Enrollment by random assignment (R), death (all‐cause), and loss to follow‐up over 6 months are shown. BA indicates balloon angioplasty; ISR, in‐stent restenosis; PEB, paclitaxel‐eluting balloon; SFA, superficial femoral artery. Ilka Ott et al. J Am Heart Assoc 2017;6:e006321 © 2017 Ilka Ott et al.

Survival free from target lesion revascularization (TLR) out to 24‐month follow‐up. Survival free from target lesion revascularization (TLR) out to 24‐month follow‐up. Kaplan–Meier curves for patients assigned to receive paclitaxel‐eluting balloon (PEB; black line) or balloon angioplasty (BA; red line). Ilka Ott et al. J Am Heart Assoc 2017;6:e006321 © 2017 Ilka Ott et al.